Dilemmas in chronic/persistent pain management
- PMID: 20350655
- DOI: 10.1016/j.disamonth.2009.12.006
Dilemmas in chronic/persistent pain management
Abstract
The burden of chronic/persistent pain is substantial for the patient and society as a whole. Although a variety of pharmacologic treatments are available, chronic/persistent pain remains inadequately treated. Many pharmacologic treatment options provide analgesic efficacy for 4 to 6 hours, requiring multiple doses for continuous pain relief. The inconvenience of multiple doses may prevent many patients from achieving adequate pain relief. Other limitations to the current pharmacologic treatment options include gastrointestinal effects, cardiovascular effects, and organ toxicity, as well as fear of abuse or addiction. The purpose of this review is to highlight the burden of chronic/persistent pain in today's society and discuss the limitations of short-acting pharmacologic therapies used in the treatment of chronic/persistent pain.
Copyright (c) 2010. Published by Mosby, Inc.
Similar articles
-
Dilemmas in chronic/persistent pain management.Am J Ther. 2008 May-Jun;15(3):256-64. doi: 10.1097/MJT.0b013e3181671c5a. Am J Ther. 2008. PMID: 18496263 Review.
-
Chronic pain of osteoarthritis: considerations for selecting an extended-release opioid analgesic.Am J Ther. 2008 May-Jun;15(3):241-55. doi: 10.1097/MJT.0b013e3181727f68. Am J Ther. 2008. PMID: 18496262 Review.
-
Evidence-based review of the pharmacoeconomics related to the management of chronic nonmalignant pain.J Pain Palliat Care Pharmacother. 2010 Jun;24(2):152-6. doi: 10.3109/15360281003713826. J Pain Palliat Care Pharmacother. 2010. PMID: 20504139 Review.
-
Opioids and the management of chronic severe pain in the elderly: consensus statement of an International Expert Panel with focus on the six clinically most often used World Health Organization Step III opioids (buprenorphine, fentanyl, hydromorphone, methadone, morphine, oxycodone).Pain Pract. 2008 Jul-Aug;8(4):287-313. doi: 10.1111/j.1533-2500.2008.00204.x. Epub 2008 May 23. Pain Pract. 2008. PMID: 18503626
-
Pharmacologic management of sleep disturbances in noncancer-related pain.Pain Manag Nurs. 2009 Mar;10(1):3-13. doi: 10.1016/j.pmn.2008.05.002. Epub 2008 Dec 17. Pain Manag Nurs. 2009. PMID: 19264278 Review.
Cited by
-
Real-world treatment patterns and opioid use in chronic low back pain patients initiating duloxetine versus standard of care.J Pain Res. 2013 Nov 26;6:825-35. doi: 10.2147/JPR.S50323. eCollection 2013. J Pain Res. 2013. PMID: 24379695 Free PMC article.
-
Population pharmacokinetics of tanezumab in phase 3 clinical trials for osteoarthritis pain.Br J Clin Pharmacol. 2016 Apr;81(4):688-99. doi: 10.1111/bcp.12850. Epub 2016 Feb 15. Br J Clin Pharmacol. 2016. PMID: 26613544 Free PMC article.
-
Mechanisms for reducing/eliminating chronic neuropathic pain with a focus on platelet-rich plasma.Exp Biol Med (Maywood). 2025 Jun 30;250:10567. doi: 10.3389/ebm.2025.10567. eCollection 2025. Exp Biol Med (Maywood). 2025. PMID: 40661101 Free PMC article. Review.
-
Microglia Promote Increased Pain Behavior through Enhanced Inflammation in the Spinal Cord during Repeated Social Defeat Stress.J Neurosci. 2019 Feb 13;39(7):1139-1149. doi: 10.1523/JNEUROSCI.2785-18.2018. Epub 2018 Dec 17. J Neurosci. 2019. PMID: 30559153 Free PMC article.
-
Antagonism of nerve growth factor-TrkA signaling and the relief of pain.Anesthesiology. 2011 Jul;115(1):189-204. doi: 10.1097/ALN.0b013e31821b1ac5. Anesthesiology. 2011. PMID: 21602663 Free PMC article.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical